Stewart appeared at NACDS TSE to support the partnership between Martha Stewart Living Omnimedia and Inergetics, as well as to promote the launch of Martha Stewart Essentials — a complete line of whole-food-based supplements specifically targeted for women.
With an all-star lineup of leading retailers and a capacity crowd once again expected for the annual Drug Store News Industry Issues Conference, DSN has added Daymond "The Shark" John as the special guest speaker at this year's event, which is scheduled for Tuesday, Dec. 3 at Manhattan's New York Athletic Club.
Blueberries. Açai berries. Tea and coffee. Tomatoes. Nuts. All of these food and beverages are rich in healthy antioxidants, and a slew of advertisements and articles tout them as such. The only problem is that most Americans don't know what antioxidants or their health benefits are, according to a new study.
Reckitt Benckiser named Alexander Lacik, 48, to the position of president, Reckitt Benckiser North America, effective June 2013. Lacik reports directly to Rob de Groot, EVP Europe and North America, and will be a part of the ENA leadership team.
Anda VP purchasing Marc Falkin wrote in an email to coworkers and friends that he would begin working for Actavis as VP marketing, pricing and contract operations for the Parsippany, N.J.-based drug maker's generics business.
While rates of human papillomavirus infection among girls ages 14 years to 19 years have dropped by half since the Centers for Disease Control and Prevention started recommending routine vaccination against it seven years ago, rates of vaccination have not increased, the agency said.
A new track-and-trace bill that the Senate is expected to consider would institute a nationwide "track-and-trace" system in place of patchwork state laws with the aim of securing the pharmaceutical supply chain.
Witherspoon lauds a 27-year history in consumer packaged goods at P&G, beginning his career in field advertising and securing positions of increasing responsibility in customer business development across multiple categories and customers and global regions.
A new bill would exempt user fees paid by drug companies to the Food and Drug Administration — including those of generic drug makers — from the automatic federal budget cuts that went into effect in March, commonly known as the sequester.